ProstaLund investor relations material

Listen to the latest call from ProstaLund

ProstaLund AB develops and sells urological devices for the treatment of patients with benign prostatic hyperplasia (BPH) internationally. The company offers BeeVital, a non-surgical therapy for BPH. It also provides Revive Flow, a laser treatment for neurogenic bladder; and Revive Basal, a drug for neurogenic bladder. The company distributes its products in the United States, Latin America, Canada, Europe, and Australia through specialized support centers. ProstaLund is hardquartered in Lund, Sweden.

Dig deeper into the ProstaLund fundamentals on Quartr.